PB2442: BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION

Detalles Bibliográficos
Autores principales: Mancusi, Antonella, Zorutti, Francesco, Ruggeri, Loredana, Bonato, Samanta, Tricarico, Sara, Zei, Tiziana, Iacucci Ostini, Roberta, Viglione, Valerio, Sembenico, Rebecca, Cardinali, Valeria, Fabrizio Martelli, Massimo, Mecucci, Cristina, Paola Martelli, Maria, Carotti, Alessandra, Velardi, Andrea, Pierini, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428711/
http://dx.doi.org/10.1097/01.HS9.0000976472.04832.a9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428711/
http://dx.doi.org/10.1097/01.HS9.0000976472.04832.a9

Ejemplares similares